Regulus Therapeutics
RGLS
#7006
Rank
$0.18 B
Marketcap
$2.88
Share price
0.00%
Change (1 day)
246.99%
Change (1 year)

Operating Margin for Regulus Therapeutics (RGLS)

Operating Margin as of March 2024 (TTM): -119.48%

According to Regulus Therapeutics's latest financial reports and stock price the company's current Operating Margin is -119.48%. At the end of 2020 the company had an Operating Margin of -157.21%.

Operating Margin history for Regulus Therapeutics from 2012 to 2020

Operating Margin at the end of each year

Year Operating Margin Change
2020-157.21%-42.23%
2019-272.12%-99.6%
2018-67,565.28%-32.53%
2017-100,141.67%1361.01%
2016-6,854.27%2451.52%
2015-268.64%-63.65%
2014-739.07%673.78%
2013-95.51%-30.36%
2012-137.15%155.7%
2011-53.64%-70.41%
2010-181.25%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
18.21%-115.24%๐Ÿ‡ซ๐Ÿ‡ท France
31.30%-126.20%๐Ÿ‡บ๐Ÿ‡ธ USA
19.24%-116.10%๐Ÿ‡บ๐Ÿ‡ธ USA
5.63%-104.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
22.54%-118.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
-160.78% 34.57%๐Ÿ‡บ๐Ÿ‡ธ USA
-61.01%-48.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-108.63%-9.08%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.